
OI Pharmapartners Ltd is a UK-based consultancy specializing in Artificial Intelligence (AI) and health economics for the life sciences and healthcare sectors. Leveraging over 30 years of experience, they provide expert advice and tailored solutions to help organizations adopt and evaluate AI and ML technologies for drug discovery, clinical development, and healthcare system efficiency. Their services include guiding clients on AI investments, developing health economic cases for interventions, and providing comprehensive analysis to improve operations, reduce costs, and drive innovation. The company's founder, Jackie Hunter CBE, has significant experience in AI adoption within drug discovery, while Nichola Naylor brings expertise in health economics and R for healthcare interventions, having advised organizations like the World Health Organization.

OI Pharmapartners Ltd is a UK-based consultancy specializing in Artificial Intelligence (AI) and health economics for the life sciences and healthcare sectors. Leveraging over 30 years of experience, they provide expert advice and tailored solutions to help organizations adopt and evaluate AI and ML technologies for drug discovery, clinical development, and healthcare system efficiency. Their services include guiding clients on AI investments, developing health economic cases for interventions, and providing comprehensive analysis to improve operations, reduce costs, and drive innovation. The company's founder, Jackie Hunter CBE, has significant experience in AI adoption within drug discovery, while Nichola Naylor brings expertise in health economics and R for healthcare interventions, having advised organizations like the World Health Organization.